Eagle’s syndrome is a condition characterized by the elongation of the styloid process or calcification of the styloid ligament, leading to compression of surrounding anatomical structures. Initially considered rare, recent studies, especially in the Indian population, suggest that its prevalence may be higher than previously thought. This syndrome, first described by Watt W. Eagle in 1937, can cause symptoms such as neck pain, odynophagia, and headaches, often misdiagnosed due to their nonspecific nature. Etiopathogenesis includes theories like trauma-induced reactive hyperplasia and hormonal influences, particularly in postmenopausal women. The incidence of elongated styloid processes in the general population ranges from 4% to 10%, although symptomatic cases of Eagle’s syndrome remain rare. In India, the prevalence varies significantly across regions, with higher rates noted in specific populations due to factors such as lifestyle and ageing. Diagnosis often relies on clinical evaluation, particularly the palpation of the styloid process through the tonsillar fossa, supported by imaging techniques like orthopantomographs (OPG) and CT scans. The management of Eagle’s syndrome includes both conservative and surgical options. Conservative treatments involve medications like gabapentin and anti-inflammatory drugs, while surgical resection of the styloid process offers a more definitive solution. The transoral approach is commonly used in India due to its minimal invasiveness and faster recovery. Understanding and early recognition of Eagle’s syndrome are crucial for improving patient outcomes, especially given the challenges of delayed diagnosis and variable presentations. Further research is essential to refine diagnostic and therapeutic strategies.